Feb 19, 2026 10:25AM
Feb 18, 2026 08:14AM
Feb 17, 2026 04:06PM
Feb 3, 2026 09:29AM
Jan 29, 2026 06:49AM
Jan 29, 2026 04:44AM
Jan 28, 2026 06:41AM Halozyme provides preliminary 2025 revenue estimates
Jan 8, 2026 09:30AM
Dec 5, 2025 05:18AM
Dec 4, 2025 01:28PM
Dec 4, 2025 06:51AM
Nov 28, 2025 06:34AM
Nov 17, 2025 11:21AM
Nov 7, 2025 08:31AM FDA approves DARZALEX Faspro for high-risk smoldering multiple myeloma
Nov 4, 2025 05:03AM
Nov 3, 2025 04:02PM
Oct 21, 2025 06:46AM
Oct 14, 2025 01:26PM
Oct 2, 2025 06:42AM
Oct 2, 2025 04:28AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM
Oct 1, 2025 04:21AM
Sep 24, 2025 08:20AM
Sep 22, 2025 06:42AM
Aug 12, 2025 04:59AM
Aug 6, 2025 04:08AM
Aug 6, 2025 03:37AM Morgan Stanley Upgrades Halozyme Therapeutics (HALO) to Overweight
Aug 5, 2025 04:05PM
Jul 23, 2025 11:39AM
Jul 10, 2025 06:28AM
Jun 30, 2025 04:07PM
Jun 20, 2025 01:15PM
Jun 10, 2025 10:00AM
May 29, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
May 28, 2025 08:31AM
May 14, 2025 04:50AM
May 14, 2025 04:13AM
May 14, 2025 03:12AM
May 13, 2025 02:44PM
May 13, 2025 08:50AM
May 7, 2025 10:47AM Benchmark Reiterates Hold Rating on Halozyme Therapeutics (HALO)
May 6, 2025 11:36PM
May 6, 2025 04:17PM
Apr 28, 2025 07:31AM
Apr 25, 2025 06:53AM
Apr 24, 2025 08:34AM
Apr 21, 2025 06:41AM
Apr 9, 2025 08:45AM Halozyme Therapeutics (HALO) Announces EU Approval of Subcutaneous DARZALEX-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligi
Apr 7, 2025 09:29AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All